iSpecimen Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
iSpecimen Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q4 2024.
  • iSpecimen Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$5.84M, a 103% decline year-over-year.
  • iSpecimen Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$12.7M, a 14% decline year-over-year.
  • iSpecimen Inc. annual Operating Income (Loss) for 2024 was -$12.7M, a 14% decline from 2023.
  • iSpecimen Inc. annual Operating Income (Loss) for 2023 was -$11.2M, a 9.65% decline from 2022.
  • iSpecimen Inc. annual Operating Income (Loss) for 2022 was -$10.2M, a 71.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$12.7M -$5.84M -$2.97M -103% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-14
Q3 2024 -$9.76M -$1.71M +$489K +22.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$10.2M -$2.18M +$1.38M +38.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$11.6M -$3M -$458K -18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$11.2M -$2.87M -$729K -34.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-14
Q3 2023 -$10.4M -$2.19M +$907K +29.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$11.3M -$3.56M -$977K -37.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$10.4M -$2.54M -$184K -7.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$10.2M -$2.14M -$147K -7.35% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$10M -$3.1M -$1.64M -113% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$8.4M -$2.59M -$1.06M -69.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$7.34M -$2.36M -$1.42M -150% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$5.93M -$1.99M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-30
Q3 2021 -$1.46M -$736K -102% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$1.53M -$1.22M -401% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$943K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$723K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$305K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.